Reinstatement of temporary suspension of prior authorization for inpatient rehabilitation hospital and long-term care hospital admissions under NC Medicaid Managed Care.
Topics Related to COVID-19
Emergency use of Evusheld approved by FDA
Providers should bill with Revenue Code 0771 instead of Revenue Code 0261 on future claims for the vaccine and monoclonal antibody administration services.
Reimbursement for COVID-19 Specimen Collection
This group includes MAFDN Family Planning Medicaid and uninsured MCV beneficiaries.
Beginning Dec. 9, 2021, Medicaid and NC Health Choice will cover the Pfizer-BioNTech COVID-19 vaccine booster dose for administration to individuals age 16 and older.
COVID-19 vaccination has been approved for all pediatric patients who meet specific criteria regarding COVID-19.
Effective Dec. 31, 2021, NC Medicaid will end several of the temporary COVID-19 rate increases. Some of the rate increases in effect in December 2021 will be extended – at either current or revised levels - through Jan. 31, 2022.
In order to ensure optimal access to care for NC Medicaid beneficiaries and to support providers during the recent COVID-19 surge, NC Medicaid is extending the Hospital at Home program through March 31, 2022.
The Food and Drug Administration and the Advisory Committee on Immunization Practices have authorized COVID-19 boosters for all adults (18 years and older).